Masitinib mesylate is the orally bioavailable mesylate salt of masitinib, a multi-targeted protein tyrosine kinase inhibitor. It selectively binds to and inhibits several receptor tyrosine kinases, including wild-type and mutated forms of c-Kit, PDGFR, and FGFR3, thereby potentially inhibiting tumor cell proliferation.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1048007-93-7
(3S,4S)-3-Hexyl-4-((R)-2-hydroxytridecyl)-2-oxetanone
Orlistat USP reference standard
(+)-geosmin
api standard for analysis
2-(tert-Butylamino)-3'-bromopropiophenone Hydrochloride
active pharmaceutical ingredient impurity
2-(tert-butylamino)-1-(4-chlorophenyl)propan-1-one hydrochloride
active pharmaceutical ingredient
methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide
TXCWBWKVIZGWEQ-UHFFFAOYSA-N
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5.CS(=O)(=O)O